The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Baker Mark Robert since 2006.
The trader's CIK number is 1331438.
At the time of the last reporting, Baker Mark Robert was the General Counsel of Progenics Pharmaceuticals Inc. (stock ticker symbol PGNX).
Also see all insider trading activities at Progenics Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | PGNX | 1,865 | $6,901 | 0 | $0 | 0 | $0 |
| 2012 | PGNX | 119,701 | $244,618 | 0 | $0 | 0 | $0 |
| 2011 | PGNX | 3,135 | $20,803 | 634 | $3,455 | 33,555 | $174,510 |
| 2010 | PGNX | 0 | $0 | 4,493 | $24,724 | 31,140 | $133,517 |
| 2009 | PGNX | 0 | $0 | 0 | $0 | 22,419 | $123,952 |
| 2008 | PGNX | 0 | $0 | 0 | $0 | 13,100 | $128,167 |
| 2007 | PGNX | 0 | $0 | 0 | $0 | 6,139 | $118,029 |
| 2006 | PGNX | 0 | $0 | 0 | $0 | 4,722 | $110,833 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-27 | PGNX | Buy | 650 | 5.34 | 3,469 |
| 2013-01-22 | PGNX | Buy | 1,215 | 2.83 | 3,432 |
| 2012-12-26 | PGNX | Buy | 1,142 | 3.01 | 3,437 |
| 2012-11-28 | PGNX | Buy | 1,607 | 2.13 | 3,419 |
| 2012-11-19 | PGNX | Buy | 11,800 | 1.96 | 23,104 |
| 2012-11-16 | PGNX | Buy | 49,793 | 1.82 | 90,722 |
| 2012-11-15 | PGNX | Buy | 48,833 | 1.69 | 82,332 |
| 2012-10-24 | PGNX | Buy | 1,162 | 2.96 | 3,433 |
| 2012-09-26 | PGNX | Buy | 1,036 | 3.32 | 3,439 |
| 2012-08-22 | PGNX | Buy | 815 | 4.23 | 3,450 |
| 2012-07-25 | PGNX | Buy | 346 | 10.04 | 3,472 |
| 2012-06-27 | PGNX | Buy | 375 | 9.27 | 3,474 |
| 2012-05-23 | PGNX | Buy | 445 | 7.81 | 3,475 |
| 2012-04-25 | PGNX | Buy | 348 | 10.10 | 3,514 |
| 2012-03-28 | PGNX | Buy | 343 | 10.12 | 3,472 |
| 2012-02-22 | PGNX | Buy | 369 | 9.44 | 3,484 |
| 2012-01-25 | PGNX | Buy | 364 | 9.50 | 3,458 |
| 2012-01-11 | PGNX | Buy | 391 | 8.87 | 3,466 |
| 2011-10-26 | PGNX | Buy | 532 | 6.52 | 3,467 |
| 2011-11-23 | PGNX | Sale | 634 | 5.45 | 3,455 |
| 2011-10-03 | PGNX | Option Ex | 5,124 | 4.62 | 23,693 |
| 2011-09-28 | PGNX | Buy | 542 | 6.38 | 3,460 |
| 2011-08-24 | PGNX | Buy | 571 | 6.08 | 3,471 |
| 2011-07-27 | PGNX | Buy | 567 | 6.12 | 3,471 |
| 2011-07-01 | PGNX | Option Ex | 20,032 | 5.46 | 109,374 |
| 2011-06-22 | PGNX | Buy | 490 | 7.08 | 3,469 |
| 2011-05-25 | PGNX | Buy | 486 | 7.13 | 3,465 |
| 2011-04-27 | PGNX | Buy | 479 | 7.24 | 3,467 |
| 2011-04-01 | PGNX | Option Ex | 4,022 | 5.05 | 20,311 |
| 2011-01-03 | PGNX | Option Ex | 4,377 | 4.83 | 21,132 |
| 2010-10-01 | PGNX | Option Ex | 17,545 | 4.32 | 75,759 |
| 2010-07-01 | PGNX | Option Ex | 4,575 | 4.44 | 20,313 |
| 2010-06-22 | PGNX | Sale | 2,328 | 5.66 | 13,185 |
| 2010-04-01 | PGNX | Option Ex | 4,300 | 4.56 | 19,590 |
| 2010-03-18 | PGNX | Sale | 2,165 | 5.33 | 11,539 |
| 2010-01-04 | PGNX | Option Ex | 4,720 | 3.78 | 17,855 |
| 2009-10-01 | PGNX | Option Ex | 3,999 | 4.26 | 17,031 |
| 2009-07-01 | PGNX | Option Ex | 13,207 | 5.33 | 70,393 |
| 2009-04-01 | PGNX | Option Ex | 3,180 | 5.65 | 17,967 |
| 2009-01-02 | PGNX | Option Ex | 2,033 | 9.13 | 18,561 |
| 2008-10-01 | PGNX | Option Ex | 2,393 | 6.53 | 15,626 |
| 2008-10-01 | PGNX | Option Ex | 2,393 | 6.53 | 15,626 |
| 2008-07-01 | PGNX | Option Ex | 4,865 | 13.64 | 66,358 |
| 2008-04-01 | PGNX | Option Ex | 2,533 | 6.52 | 16,515 |
| 2008-01-02 | PGNX | Option Ex | 916 | 15.33 | 14,042 |
| 2007-10-01 | PGNX | Option Ex | 748 | 19.03 | 14,234 |
| 2007-10-01 | PGNX | Option Ex | 748 | 19.03 | 14,234 |
| 2007-07-02 | PGNX | Option Ex | 3,451 | 18.71 | 64,568 |
| 2007-04-02 | PGNX | Option Ex | 621 | 20.13 | 12,500 |
| 2007-01-03 | PGNX | Option Ex | 571 | 21.88 | 12,493 |
| 2006-10-02 | PGNX | Option Ex | 627 | 19.58 | 12,276 |
| 2006-07-03 | PGNX | Option Ex | 3,056 | 25.01 | 76,430 |
| 2006-04-03 | PGNX | Option Ex | 500 | 21.77 | 10,884 |
| 2006-01-03 | PGNX | Option Ex | 539 | 20.86 | 11,243 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Mark Robert (General Counsel of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.